Johnson & Johnson Covid-19 Vaccine Recipients Often Shift to Other Boosters

Johnson & Johnson’s Covid-19 vaccine hasn’t been the booster shot of choice. Most people originally vaccinated with J&J’s shot are choosing other vaccines if they get a booster, new government data show, partly reflecting concerns about the lower effectiveness of the drugmaker’s vaccine. So far, about 1.7 million people of the 15.7 million who originally got J&J’s single-dose vaccine have received a booster. Of these, 26% stayed with J&J for their second dose through Wednesday, according to the U.S. Centers for Disease Control and Prevention. The rest of those originally immunized with J&J’s shot and later got boosters received other drugmakers’ vaccines. Some 43% got the Moderna Inc. MRNA vaccine, the CDC said, while 31% received a booster from Pfizer Inc. and partner BioNTech